Search research articles
Contact Us
Filters
Showing results (161-170 of 182) with videos related to
Page
of 19
Sort By:
Radiation Oncology Journal
|
July 1, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Urology
|
December 3, 2014
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy
Wan Song, Seol Ho Choo, Hyun Hwan Sung, et al.
Journal of Medical Imaging and Radiation Oncology
|
March 13, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Journal of Korean Medical Science
|
August 5, 2015
Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea
Sung Han Kim, Ho Kyung Seo, Hee Chul Shin, et al.
BMC Urology
|
May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
Sang Eun Yoon, Youjin Kim, Jangho Cho, et al.
European Radiology
|
February 1, 2015
Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance
Tae Heon Kim, Jae Yong Jeong, Sin Woo Lee, et al.
BMC Urology
|
August 24, 2017
A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer
Hae Su Kim, Ji Yun Lee, Su Jin Lee, et al.
Prostate International
|
September 25, 2023
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Translational Oncology
|
March 23, 2017
Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma
Jiryeon Jang, Oliver Rath, Julia Schueler, et al.
Cancers
|
December 24, 2021
Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Ji Hyun Lee, Byul A Jee, Jae-Hun Kim, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 182) with videos related to
Sort By:
Page
of 19
Radiation Oncology Journal
|
July 1, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for clinically node-positive prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Urology
|
December 3, 2014
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy
Wan Song, Seol Ho Choo, Hyun Hwan Sung, et al.
Journal of Medical Imaging and Radiation Oncology
|
March 13, 2024
Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Journal of Korean Medical Science
|
August 5, 2015
Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea
Sung Han Kim, Ho Kyung Seo, Hee Chul Shin, et al.
BMC Urology
|
May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
Sang Eun Yoon, Youjin Kim, Jangho Cho, et al.
European Radiology
|
February 1, 2015
Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance
Tae Heon Kim, Jae Yong Jeong, Sin Woo Lee, et al.
BMC Urology
|
August 24, 2017
A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer
Hae Su Kim, Ji Yun Lee, Su Jin Lee, et al.
Prostate International
|
September 25, 2023
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, et al.
Translational Oncology
|
March 23, 2017
Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma
Jiryeon Jang, Oliver Rath, Julia Schueler, et al.
Cancers
|
December 24, 2021
Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Ji Hyun Lee, Byul A Jee, Jae-Hun Kim, et al.
Page
of 19